Abstract Background: Standard medications for opioid use disorder (MOUD) provide effective treatment pathways for recovery compared with no treatment or…
Abstract Abstract: Introduction: Cannabis use disorder (CUD) affects ∼33 million people globally and can be underscored by intense cravings to…
Abstract Cue‐induced craving—the desire to use a drug triggered by exposure to cues associated with prior use—is a central mechanism…
Abstract Background: Standard medications for opioid used disorder (MOUD) provide effective treatment pathways for recovery compared with no treatment or…
Abstract Substance use disorders (SUDs) are widely prevalent in many countries, with the highest rates observed in nicotine and alcohol…
Abstract Background: Alcohol and cannabis are commonly used together by young adults. With frequent pairings, use of one substance may…
Abstract Glucagon-like peptide-1 (GLP-1) is involved in a range of central and peripheral pathways related to appetitive behavior. Hence, this…
Abstract Introduction: Opioid use disorder (OUD) continues to be a significant public health concern. Medications for OUD (MOUD) such as…
Abstract Background: Opioid use disorder (OUD) remains a major public health concern. Despite the use of medications for OUD such…
Abstract Purpose of Review: This review summarizes recent clinical trial research on pharmacological treatments for substance use disorders, with a…